Dr. Tejinder S. Glamour, MD

Dr. Glamour practices at West Central Gastroenterology in Saint Petersburg, Florida.

Dr. Glamour's NPI, 1043282569, was assigned on February 7, 2006. Dr. Glamour graduated from Dayanand Medical College in 1985. Dr. Glamour holds Florida license ME68156.

Dr. Glamour's primary practice is West Central Gastroenterology, at 1201 5th N Ave, Saint Petersburg, FL 33705 in Pinellas County. The practice phone is (727) 347-0005.

Dr. Glamour's primary practice is West Central Gastroenterology in Saint Petersburg, Florida. Dr. Glamour is also affiliated with BayCare St. Anthony's Hospital. The medical group on file is Gastro Florida. Dmand AI also links Dr. Glamour to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Glamour practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Glamour's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Glamour is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Glamour's licenses on file in 3 states: Florida, New Jersey and Ohio.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroduodenitis, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Glamour treats.

CMS data shows 1,044 Medicare services from Dr. Glamour across 11 procedure codes in 2024, for 477 Medicare patients. Medicare paid $95,509 for them.

CMS counts 477 Medicare patients who saw Dr. Glamour in 2024. The largest group is 65 to 74, with 256 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Glamour's median patient age at 68, with 59% women.

In 2024, Dr. Glamour wrote 2,041 Medicare Part D claims for 789 patients. 65% of them were for generic drugs. CMS names the drug for 1,801 of them, across 34 drugs with 11 or more claims each, at $1,557,301 in total drug cost. In 2023, CMS named 1,590 claims across 37 drugs.

Dr. Glamour accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 129 procedures of colonoscopy by Dr. Glamour, more than 86% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Glamour.

Dmand AI links Dr. Glamour to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Colitis, Ulcerative and Colitis. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Glamour that name 2 trials.

CMS Open Payments shows 1,069 general payments to Dr. Glamour from 57 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 63% of the total. Gilead Sciences, Inc. paid the most, $11,804. It also lists 5 research payments totaling $3,347 from 2018 to 2020, naming 2 clinical trials.

Dmand AI lists 2 awards for Dr. Glamour, most recently CMS Stage 1 EHR in 2013.

Dr. Glamour graduated from Dayanand Medical College in 1985.

Dr. Glamour is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.